Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmed Ali Badran

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Analytical and Bioanalytical Chemistry|January 13, 2017
Simultaneous determination of four food allergens using compact disc immunoassaying technologyAhmed Ali Badran, Sergi Morais, Ángel Maquieira
Breast Care (Basel, Switzerland)|July 12, 2021
Ribociclib-Induced Pneumonitis: A Case ReportGhada Algwaiz, Ahmed Ali Badran, Mahmoud A Elshenawy, et al.
Frontiers in Oncology|June 5, 2026
Conversion and resection rates in borderline resectable and locally advanced pancreatic cancer following neoadjuvant therapy: a retrospective multicenter cohort studyAli H Aljubran, Maaz Kamal Alata, Ahmed Ali Badran, et al.
Breast Care (Basel, Switzerland)|March 15, 2021
Trastuzumab, Pertuzumab, and Docetaxel as the First Line for HER-2-Positive Metastatic Breast Cancer among ArabsKausar Suleman, Ali Hassan Mushtaq, Emaan Haque, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Analytical and Bioanalytical Chemistry|January 13, 2017
Simultaneous determination of four food allergens using compact disc immunoassaying technologyAhmed Ali Badran, Sergi Morais, Ángel Maquieira
Breast Care (Basel, Switzerland)|July 12, 2021
Ribociclib-Induced Pneumonitis: A Case ReportGhada Algwaiz, Ahmed Ali Badran, Mahmoud A Elshenawy, et al.
Frontiers in Oncology|June 5, 2026
Conversion and resection rates in borderline resectable and locally advanced pancreatic cancer following neoadjuvant therapy: a retrospective multicenter cohort studyAli H Aljubran, Maaz Kamal Alata, Ahmed Ali Badran, et al.
Breast Care (Basel, Switzerland)|March 15, 2021
Trastuzumab, Pertuzumab, and Docetaxel as the First Line for HER-2-Positive Metastatic Breast Cancer among ArabsKausar Suleman, Ali Hassan Mushtaq, Emaan Haque, et al.
Pageof 1